
Loading, please wait...

Loading, please wait...

Acute pediatric infections often drive families to emergency departments, yet many cases are manageable at home. To address this, researchers are developing a pediatric AI chatbot named CHAMP (CHatbot to Assist the Management of Pediatric patients). This innovative tool provides timely, tailored, and validated health information to help parents make informed care-seeking decisions. By bridging the gap between clinical expertise and at-home care, CHAMP aims to optimize healthcare resource utilization.
The CHAMP project employs a multiphase, mixed-methods participatory study design at the Montreal Children's Hospital. Initially, the team conducts a qualitative needs assessment to understand family preferences regarding pediatric infections. Subsequently, a coconstruction committee of parents and youth reviews clinical guidelines to map essential care questions. Furthermore, the study includes iterative prototyping and scenario testing to ensure high usability and acceptability among diverse users. Additionally, researchers evaluate an automated large language model-based translation layer to enhance multilingual accessibility.
Consequently, the study ensures that the final prototype is grounded in equitable and responsible AI development. Because the tool focuses on acute infectious symptoms, it addresses a major pain point in pediatric primary care. Moreover, the participatory approach empowers families as coresearchers, ensuring the technology aligns with their real-world needs. Therefore, CHAMP represents a significant step toward patient-centered digital health solutions.
Successful implementation of this pediatric AI chatbot could significantly reduce preventable emergency department visits. Furthermore, it ensures that high-risk children receive timely direction to appropriate clinical care. In the future, findings from this study will inform broader best practices for pediatric-centered AI health tools. Ultimately, such innovations improve the overall healthcare experience for both patients and their families.
CHAMP delivers evidence-based guidance tailored to a child's symptoms, helping parents determine if they can safely manage the illness at home or if they need to seek medical attention.
The chatbot is being coconstructed by a committee of youth, parents, caregivers, and partners to ensure the tool meets the actual needs and concerns of its end-users.
Yes, the study specifically includes a phase to evaluate a multilingual translation layer, aiming to bridge language barriers and promote digital equity for all families.
Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Lin J et al. Coconstructing CHAMP, an Artificial Intelligence Chatbot for Pediatric Infectious Symptoms Management: Protocol for a Multiphase Participatory Study. JMIR Res Protoc. 2026 May 26. doi: 10.2196/89852. PMID: 42189574.
Varghese C et al. Artificial intelligence: Revolutionizing pediatric emergency care - A narrative review. PMC. 2025 Sep 11.
UNICEF. Policy guidance on AI for children. 2.0. 2021.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers are protocolizing CHAMP, an AI chatbot designed to provide tailored health guidance for pediatric infectious symptoms and reduce ED crowding....
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today